| |
| |
|
| Insider
Information: |
Jonas Jeffrey M |
| Relationship: |
|
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
128,046 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
128,046 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sage Therapeutics, Inc. |
SAGE |
|
2023-11-28 |
128,046 |
2014-07-23 |
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
44,115 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Innovation Officer |
• • – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
66,330 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Innovation Officer |
• • – |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
85,237 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,100 |
123,408 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
|
– • – |
2023-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
990 |
990 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2023-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
131,981 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Innovation Officer |
• • – |
2021-01-27 |
4 |
OE |
$0.45 |
$810 |
D/D |
1,800 |
56,330 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Innovation Officer |
• • – |
2022-02-17 |
4 |
OE |
$0.45 |
$1,800 |
D/D |
4,000 |
84,863 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-09-11 |
4 |
OE |
$0.45 |
$2,070 |
D/D |
4,600 |
47,030 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-01-09 |
4 |
OE |
$0.45 |
$4,500 |
D/D |
10,000 |
62,115 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2023-02-10 |
4 |
OE |
$0.45 |
$5,239 |
D/D |
11,643 |
133,624 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Innovation Officer |
• • – |
2021-06-16 |
4 |
OE |
$0.45 |
$5,400 |
D/D |
12,000 |
75,237 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2017-12-22 |
4 |
OE |
$0.45 |
$5,739 |
D/D |
12,753 |
13,979 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
See Remarks |
• • – |
2016-01-07 |
4 |
OE |
$0.45 |
$9,000 |
D/D |
20,000 |
101,226 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
See Remarks |
• • – |
2015-12-31 |
4 |
B |
$49.56 |
$11,201 |
D/D |
226 |
81,226 |
2.81 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-07-16 |
4 |
OE |
$0.45 |
$12,150 |
D/D |
27,000 |
39,115 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2022-04-27 |
4 |
OE |
$0.45 |
$13,925 |
D/D |
30,944 |
115,807 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-05-28 |
4 |
OE |
$0.45 |
$16,081 |
D/D |
35,736 |
97,851 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-05-24 |
4 |
OE |
$0.45 |
$18,160 |
D/D |
40,356 |
102,471 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-05-23 |
4 |
OE |
$0.45 |
$24,259 |
D/D |
53,908 |
116,023 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2017-12-21 |
4 |
OE |
$0.45 |
$49,611 |
D/D |
110,247 |
211,473 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
See Remarks |
• • – |
2015-06-15 |
4 |
OE |
$0.45 |
$52,254 |
D/D |
116,119 |
38,745 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2023-02-03 |
4 |
D |
$44.16 |
$63,016 |
D/D |
(1,427) |
121,981 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2023-01-03 |
4 |
OE |
$28.63 |
$71,604 |
D/D |
2,501 |
118,308 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
See Remarks |
• • – |
2015-06-16 |
4 |
OE |
$0.45 |
$72,216 |
D/D |
160,481 |
84,000 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
